Table 3. Peak symptom-limited incremental treadmill exercise.
GOLD 1 | GOLD 2 | Control | |
n = 41 | n = 63 | n = 104 | |
Work rate (W) | 116±42*** | 106±31*** | 196±67 |
Dyspnea Borg scale† | 5.6±2.5 | 5.5±2.4 | 5.0±2.8 |
Leg discomfort Borg scale† | 4.7±2.8 | 5.3±2.6 | 4.7±2.8 |
![]() |
1.81±0.59*** | 1.62±0.41*** , # | 2.17±0.70 |
![]() |
1.94±0.71*** | 1.69±0.47*** , # | 2.46±0.79 |
![]() |
35.3±6.6*** | 33.8±12.1** | 29.3±3.9 |
![]() |
67.1±23.6 | 55.1±15.4*** , ### | 71.5±23.4 |
Breathing reserve (L/min)† | 25.6±15.4*** | 9.6±14.3*** , ### | 37.3±19.9 |
![]() |
72±14 | 87±20*** , ### | 66±16 |
Vt (L)† | 1.92±0.59*** | 1.57±0.44*** , ### | 2.17±0.66 |
Fb (breaths/min)† | 35.4±7.6 | 35.7±7.3 | 33.4±6.6 |
Ti/Ttot † | 0.44±0.05 | 0.41±0.06*** , ## | 0.45±0.06 |
IC (L) | 2.67±0.78** | 2.17±0.59*** , ### | 2.90±0.81 |
ΔIC peak–rest (L) | –0.52±0.44*** | –0.42±0.31*** | 0.01±0.39 |
IRV (L)† | 0.75±0.40 | 0.60±0.40* | 0.73±0.36 |
EELV (L) | 4.00±1.11*** | 3.85±0.87*** | 2.87±0.78 |
SpO2 minimum (%)† | 94.4±2.8 | 93.5±2.9** | 94.9±2.7 |
Data are presented as mean ± standard deviation.
GOLD, Global Initiative for Chronic Obstructive Lung Disease; , oxygen uptake;
, carbon dioxide production;
, minute ventilation; MBC, maximum breathing capacity; Vt, tidal volume; Fb, breathing frequency; Ti, inspiratory time; Ttot, total respiratory time; Ti
/Ttot, inspiratory duty cycle; IC, inspiratory capacity; Δ, change; IRV, inspiratory reserve volume; EELV, end-expiratory lung volumes; SpO2, arterial oxygen saturation measured by pulse oximetry.
P-values are from a linear regression model, adjusted for age, sex, alcohol status, employment status, and body mass index.
*p<0.05 versus control;
**p<0.01 versus control;
***p<0.001 versus control
p<0.05 GOLD 1 versus GOLD 2;
p<0.01 GOLD 1 versus GOLD 2;
p<0.001 GOLD 1 versus GOLD 2.
GOLD 2, n = 62.